RadNet, Inc. (NASDAQ:RDNT) is one of the 10 Best Diagnostics and Research Stocks to Buy According to Analysts. RadNet (RDNT) Acquires Gleamer for €230 Million On March 2, 2026, RadNet, Inc. (NASDAQ:RDNT) announced the acquisition of Paris-based Gleamer SAS for up to €230 million. The acquisition positions the company’s subsidiary, DeepHealth, as the world’s largest radiology AI provider. Gleamer services 700 global contracts. It reported a 90% ARR growth rate between 2022 and 2025 and is expected to reac ...